Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
104.6 USD | -1.52% | -1.32% | -4.71% |
04-29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
04-26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.71% | 185B | |
-0.75% | 109B | |
-4.07% | 68.54B | |
+4.23% | 51.74B | |
+10.02% | 45.22B | |
+3.12% | 41.74B | |
+4.22% | 26.83B | |
+3.17% | 26.69B | |
+11.62% | 25.63B | |
-1.13% | 24.98B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- UBS Raises Abbott Laboratories Price Target to $143 from $136, Buy Rating Kept